Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001309210 | SCV001498702 | benign | Alagille syndrome due to a JAG1 point mutation | 2023-11-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002437057 | SCV002752245 | uncertain significance | Cardiovascular phenotype | 2021-08-22 | criteria provided, single submitter | clinical testing | The p.P943L variant (also known as c.2828C>T), located in coding exon 23 of the JAG1 gene, results from a C to T substitution at nucleotide position 2828. The proline at codon 943 is replaced by leucine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002476429 | SCV002783043 | uncertain significance | Alagille syndrome due to a JAG1 point mutation; Tetralogy of Fallot; Deafness, congenital heart defects, and posterior embryotoxon; Charcot-Marie-Tooth disease, axonal, Type 2HH | 2021-11-12 | criteria provided, single submitter | clinical testing |